Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch...
System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(70)
•••
on-target
X
View Profile
View Bullboard History
Comment by
on-target
on May 28, 2024 9:38am
RE:Rigby will give a huge boost to SVA
Mr. Rigby served as the CEO for SteadyMed Therapeutics (NASDAQ:STDY), which he listed on Nasdaq prior to its acquisition by United Therapeutics (NASDAQ:UTHR), and was co-founder of
...more
(119)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on May 28, 2024 8:17am
Rigby will give a huge boost to SVA
I like it. This addition is very positive for Sernova! GLTA
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2%
posted May 28, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur's first international distribution agreement is over a three-year term with a company specializing in the sale of radiology products in Latin America. This initial agreement grants the distributor marketing and sales rights in two countries, for SmoothX 2%, a contrast medium for use in abdominal Computed Tomography (CT) diagnostic examinations. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 28, 2024 7:00am
New Press Release - Sernova Appoints Jonathan Rigby to its Board of Directors
(TheNewswire)LONDON, Ontario; BOSTON, Massachusetts – May 28, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chronic diseases, announces today...
read article.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on May 23, 2024 6:00am
Buzz on the Bullboards: Tech gains amid weak commodities
Weak commodity prices and a significant sell-off among heavyweight financial shares counterbalanced gains.
read article.
(119)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on May 22, 2024 9:04am
RE:If someone needs to sell 200K shares today,,
Sorry everyone. Wrong board. SMH.
(119)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on May 22, 2024 9:02am
If someone needs to sell 200K shares today,,
,, the sp would go from 12 cents down to 8 cents. That would be a huge drop %age wise. Big buyers at 10 cents seem to have taken their bids off the board. We'll see where this goes. GLTA
...more
(119)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on May 09, 2024 5:26pm
RE:RE:RE:RE:CEO buying SVA shares????
Hey WK. Yes I did and I still believe it. I also believe there was a lot of unneeded spending as well as internal fighting which made the SP sink, but as soon as the dust settles SVA shares will rise
...more
(393)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on May 09, 2024 9:28am
RE:RE:RE:CEO buying SVA shares????
rixpix, in all due repect didn't you say this was a gift when it was trading in the 50's a few weeks ago? Have a history here and would love to see news good enough for me to get back in
...more
(42)
•••
kriko
X
View Profile
View Bullboard History
Comment by
kriko
on May 07, 2024 7:36pm
RE:Crickets
They're all over at CEO.CA
(119)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on May 03, 2024 5:16pm
RE:RE:CEO buying SVA shares????
BUY now, and nevermind waiting for the 20s.
(3)
•••
LiquidReality
X
View Profile
View Bullboard History
Comment by
LiquidReality
on May 03, 2024 12:52am
RE:CEO buying SVA shares????
Why? Clearly something shady happened with the company's money, so that's gotta come out. And they need money soon, so I would wait for the stock to drop back down to the .20s and they do a
...more
(119)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on May 02, 2024 4:46pm
CEO buying SVA shares????
She and all other insiders should buy some shares, even if it's just a small amount, as a good gesture, and to show some positive sentiment in the SP. If they're not gonna put some of
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 01, 2024 7:00am
New Press Release - Sernova Announces AGM Voting Results
(TheNewswire)LONDON,Ontario; BOSTON, Massachusetts – TheNewswire – May 1, 2024, Sernova Corp. (“Sernova” or the “Corporation”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chronic...
read article.
(119)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Apr 28, 2024 7:14pm
RE:RE:Never fall in love with a stock you own
No , Clark. I highly doubt you know how i feel. I've been in Sernova before it was called Sernova. Over 20 years and counting. Watched the SP become a 10 bagger and didn't sell a share.
...more
(1)
•••
clarkkent
X
View Profile
View Bullboard History
Comment by
clarkkent
on Apr 27, 2024 11:06am
RE:Never fall in love with a stock you own
Have been in this since 2019 so I know how you feel! If they can eventually get to commercialization the SP will soar or more likely somebody like Novo Nordisk will take them out because Insulin is a
...more
(119)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Apr 26, 2024 4:44pm
RE:Never fall in love with a stock you own
Pleasantly surprised to see the SP rise today. I think everyone was anticipating a down day. Now if some insiders can start buying, that would really be a good sign!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year
April Sees Record Revenue for Cannabis Edibles Leader and Eyes Record Profitability in 2024